Lipofen(Fenofibrate)

Product name : Lipofen(Fenofibrate)

CAS : 49562-28-9

Molecular formula : C₂₀H₂₁ClO₄

Molecular weight : 360.84

Product Description :
Fenofibrate is a drug of the fibrate class. Fenofibrate was developed by Groupe Fournier SA, before it was acquired in 2005 by Solvay Pharmaceutical, a business unit owned by the Belgian corporation, Solvay S.A. It is mainly used to reduce cholesterol levels in patients at risk of cardiovascular disease. Like other fibrates, it reduces both low-density lipoprotein (LDL) and very low density lipoprotein (VLDL) levels, as well as increasing high-density lipoprotein (HDL) levels and reducing tryglycerides level. It also appears to have a beneficial effect on the insulin resistance featured by the metabolic syndrome. It is used alone or in conjunction with statins in the treatment of hypercholesterolemia and hypertriglyceridemia. Fenofibrate is sold under the brand name Tricor and Trilipix by Abbott Labs, Lipofen by Kowa Pharmaceuticals America Inc, Lofibra by Teva, Lipanthyl, Lipidil, and Supralip by Solvay Pharmaceutical, Fenocor-67 by Ordain Health Care Pvt Ltd, Fenogal by SMB Laboratories, and Antara by Oscient Pharmaceuticals.